Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-06

Clinical Trial Update: Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing chlorambucil alone, chlorambucil with rituximab, and rituximab alone in MALT lymphoma has been completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorambucil (chlorambucil)
  • Rituximab (rituximab)

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Lymphoma, Mucosa-Associated Lymphoid Tissue | Phase 3 | Status: COMPLETED | Results posted: 2019-06-06